The combination of the farnesyl transferase inhibitor lonafarnib and the proteasome inhibitor bortezomib induces synergistic apoptosis in human myeloma cells that is associated with down-regulation of p-AKT.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples